Performance in the Centers for Medicare & Medicaid Services’ Hospital-acquired Conditions Reduction Program is heavily influenced by hospital size, according to a new study in the American Journal of Medical Quality. Researchers from the AHA, KNG Health Consulting, the Network for Excellence in Health Innovation and the Association of American Medical Colleges examined component measures of the Patient Safety Indicator 90, a composite measure intended to reflect performance on multiple types of complications. The authors simulated hospitals’ likelihood of being in the worst-performing quartile on each measure assuming identical expected complication across hospitals and found that “variations across hospitals in numbers of cases can bias the results.” According to the study, the direction of the bias depends on the expected complication rate and the distribution of eligible cases across hospitals. “Large hospitals, compared with smaller hospitals, are more likely to be identified as poor performers for measures with very low probabilities of complication. The reverse holds for measures with higher probabilities of complication,” the authors note. In an AHA Stat blog post today, Nancy Foster, AHA vice president for quality and patient safety policy, wrote, “The way the law and CMS’s regulations set up the HAC program unfairly penalizes hospitals at both ends of the spectrum – both the larger and smaller ones,” noting that “penalties on the HAC program are more a function of math than of true underlying quality.”

Related News Articles

Headline
An estimated 23 percent of outpatient antibiotic prescriptions filled by privately insured children and non-elderly adults in the United States in 2016 were…
Insights and Analysis
Also in this weekly roundup of health-related news: treatment options scarce as meth deaths flare; app makes donating blood easier
Headline
Hospitals and health systems may apply through Feb. 19 for the 2019 AHA Equity of Care Award, which recognizes organizations participating in the AHA's #…
Insights and Analysis
At last month’s AHA Executive Forum, Kimberlydawn Wisdom, M.D., senior vice president of community health and equity and chief wellness and diversity officer…
Headline
The AHA today submitted to the Food and Drug Administration legislative, regulatory and best practice recommendations to address new and chronic prescription…
Headline
A coalition of 40 health care and public health organizations, including the AHA, today urged the Senate to quickly pass the Pandemic and All-Hazards…